Skip to main content

Table 3 HOMA-IR in relation to metabolic syndrome (ATPIII) and the number of metabolic syndrome components in patients with manifest arterial disease

From: Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

n = 2611

 

N

HOMA-IR

QUICKI

p-value

Metabolic syndrome

no

1478

2.1 ± 1.4

0.28 ± 0.05

< 0.001

 

yes

1053

3.7 ± 2.5

0.24 ± 0.04

 

Metabolic syndrome components

0

137

1.4 ± 0.7

0.31 ± 0.05

< 0.001

 

1

547

1.8 ± 1.2

0.30 ± 0.06

 
 

2

794

2.4 ± 1.5

0.27 ± 0.05

 
 

3

573

3.1 ± 1.8

0.25 ± 0.04

 
 

4

366

4.0 ± 2.6

0.23 ± 0.03

 
 

5

114

5.6 ± 3.6

0.22 ± 0.03

Â